Tatva Chintan Pharma Chem Limited · NSE:TATVA
Tatva Chintan Pharma Chem — Q4 FY23 Earnings Presentation
39 slides from Tatva Chintan Pharma Chem's earnings presentation, May 5, 2023
Slide 1: Exchange filing cover letter for Investor Presentation
Date: 05 May 2023 Ref. No.: TCPCL/SEC/2023-24/00011 To, The General Manager, The Manager, Corporate relationship department, Listing department, BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, C-1, Block-G, Dalal Street, Fort, Bandra-Kurla, Complex Ban
Slide 2: Investor Presentation Q4FY23 & FY23
Investor Presentation Tatva Chintan Pharma Chem Limited (TCPCL) Q4FY23 & FY23 05 May 2023
Slide 3: Contents
Contents 01 02 03 04 Q4FY23 & FY23 TATVA CHINTAN at Glance Product Categories Leading Sustainable Financial Performance practices coupled with cutting edge technology 05 06 07 08 Expansive international Why TATVA CHINTAN Industry Outlook Our Business presence with Marquee clientele 2
Slide 4: Consolidated Financial Performance
Consolidated Financial Performance 3
Slide 5: Q4FY23 & FY23: Result highlights
Q4FY23 & FY23: Result highlights Q4FY23 HIGHLIGHTS Revenue from Operations 1 (In ₹ Mn) EBIDTA & EBIDTA Margin 1 (In ₹ Mn, %) PAT & PAT Margin 1 (In ₹ Mn, %) 176 20% EPS (In ₹) 18% 175 18% 250 25% 174 16% 22% 1,245 173 14% 14% 220 200 20% 985 172 12% 150 15% 171 175 10% 7.90 13% 170 8% 26% 26% 3% 163
Slide 6: Q4FY23 & FY23: Operational highlights
Q4FY23 & FY23 : Operational highlights OPERATING REVENUE SPLIT (IN %) Q4FY23 PTC 30% FY23 PTC 34% SDA 44% SDA 30% ELECTROLYTE SALTS 1% ELECTROLYTE SALTS 4% PASC 24% PASC 32% OTHERS 1% OTHERS 1% Tatva Chintan Pharma Chem Limited 5
Slide 7: Q4FY23 & FY23: Consolidated P&L
Q4FY23 & FY23: Consolidated P&L Particulars (₹ Mn) Q4 FY23 Q4 FY22 YoY (%) Q3 FY23 QoQ (%) FY23 FY22 YoY (%) Revenue from Operation 1,245.11 985.31 26.37% 1,206.07 3.24% 4,236.12 4,336.47 -2.31% Total Income 1,253.56 988.42 26.82% 1,216.84 3.02% 4,293.56 4,426.64 -3.01% EBITDA (Excl. Other Income) 1
Slide 8: Chairman & MD's Comments on Results
Chairman & MD’s Comments on Results • During this quarter, the company reported the revenue from operations of ₹ 1,245 million, a growth of 26% YoY whereas the full year revenue stood at ₹ 4,236, a “ decline of 2% YoY. Despite the challenging year, we are satisfied to have achieved this scale in ter
Slide 9: Consolidated Annualized Financial Highlights
Consolidated Annualized Financial Highlights REVENUE FROM OPERATIONS1 (IN ₹ MN) PROFITABILITY1 (IN ₹ MN) EBITDA (Excluding Other Income) & EBITDA Margin PAT & PAT Margin 90 57 22% 25% 14% 14% 17% 22% 11% 21% 4,236 52 4,336 959 14 523 3,004 1,082 16% 22% 455 2,632 20% 378 664 CAGR* CAGR* 606 CAGR* 55
Slide 10: Consolidated Statement Profit & Loss
Consolidated Statement Profit & Loss As at Particulars (₹ Mn) 31 March 2019 31 March 2020 31 March 2021 31 March 2022 31 March 2023 Audited Audited Audited Audited Audited Income Revenue from operations 2,063.07 2,632.39 3,003.59 4,336.47 4,236.12 Total Income 2,068.01 2,646.22 3,055.59 4,426.64 4,2
Slide 11: Consolidated Statement Balance Sheet
Consolidated Statement Balance Sheet As at Particulars (₹ Mn) 31 March 2019 31 March 2020 31 March 2021 31 March 2022 31 March 2023 Audited Audited Audited Audited Audited Assets Fixed Assets 665.75 1,110.60 1,203.51 1,592.96 1,957.71 Capital work-in-progress 60.36 48.92 98.11 514.91 2,307.44 Intang
Slide 12: TATVA CHINTAN at Glance
TATVA CHINTAN at Glance 11
Slide 13: TATVA CHINTAN at Glance
TATVA CHINTAN at Glance INTEGRATED SPECIALTY CHEMICAL COMPANY, PRESENT ACROSS THE VALUE CHAIN • Established by first generation entrepreneur engineers in Manufacturing Products Revenue Split – FY23 1996 • Plants located at Ankleshwar and Dahej SEZ, Gujarat with an existing combined installed capacit
Slide 14: Product Categories
Product Categories » & = i © Se
Slide 15: Phase Transfer Catalyst (PTC)
Phase Transfer Catalyst (PTC) A Catalyst with Innumerable Benefits WHAT ARE PTC? BENEFITS DEMAND DRIVERS • PTC are used to facilitate the • Offers faster reactions • Rising demand for technologically Tatva Chintan’s migration of a reactant from one • Higher conversion or yields, advanced environment
Slide 16: Structure Directing Agents (SDA)
Structure Directing Agents (SDA) – An important ingredient for making the world more sustainable WHAT ARE SDA? BENEFITS DEMAND DRIVERS • High purity Quaternary salts that SDAs are important raw material for • With the recent developments in Tatva Chintan’s helps in the formation of creation of high
Slide 17: Electrolysis – A better and greener way of producing SDAs
Electrolysis – A better and greener way of producing SDAs ABOUT ELECTROLYSIS BENEFITS • Tatva started R&D into developing SDAs • Electrolysis is considered as a ‘green’ since 2007 chemistry process wherein apart from a single starting raw material, the process largely uses • In 2015, it received com
Slide 18: Electrolyte Salts – Aiding the technological thrust
Electrolyte Salts – Aiding the technological thrust WHAT ARE ELECTROLYTE BENEFITS DEMAND DRIVERS • Due to their properties like fast Tatva Chintan’s SALTS? Currently, these are used along with charging ability, superior low Lithium battery in EV vehicles PRESENCE IN SALTS • Electrolyte Salts are use
Slide 19: Pharmaceuticals and Agrochemicals Intermediates and other Specialty Chemicals (PASC)
Pharmaceuticals and Agrochemicals Intermediates and other Specialty Chemicals (PASC) WHICH PRODUCTS ARE END USER INDUSTRY APPLICATION Tatva Chintan’s MANUFACTURED? POSITION IN PASC • Various pharmaceutical and agrochemical products such as Pharmaceuticals Agro Actives 2016 Tatva is the intermediates
Slide 20: Continuous Flow Chemistry
Continuous Flow Chemistry- sophisticated method with analytical expertise ABOUT BENEFITS PROCESS • Tatva Chintan started R&D into • Continuous Flow Chemistry is • Structure directing agents are continuous flow chemistry since considered as a ‘green’ chemistry converted to Zeolite based catalysts 201
Slide 21: Value derived from Product Categories
Value derived from Product Categories REVENUE FROM EACH PRODUCT CATEGORY1 FY20:FY23 (In ₹ Mn.) 2,248 Considering the wide range of applications of our products, Tatva Chintan can cater to customers across wide spectrum of 1,432 Chemical Industries which ensures a 1,335 1,277 sustainable business mod
Slide 22: Leading Sustainable practices coupled with cutting edge technology
Leading Sustainable practices coupled with cutting edge technology 21
Slide 23: Integrated and Modern Manufacturing Facility
Integrated and Modern Manufacturing Facility ANKLESHWAR DAHEJ SEZ • Both the plants are in-close proximity to • Manufacturing facility started in 1996 • Manufacturing started in 2017 Hazira port. • Converted into a ‘zero liquid effluent discharge’ facility from • Sophisticated quality control lab eq
Slide 24: One of the prominent Research & Development center
One of the prominent Research & Development center R&D CAPITAL AND REVENUE EXPENDITURE • Dedicated R&D facility at Vadodara recognized by the Department of (In ₹ Mn.) 300 Scientific and Industrial Research (“DSIR”), Government of India. Currently spread over 10,000 Sq. ft and being expanded to 36,00
Slide 25: With a focus on 'green' chemistry processes
…With a focus on ‘green’ chemistry processes Tatva Chintan’s ‘green’ chemistry is based on the principles of clean chemistry, minimum requirement of auxiliary substances, minimum waste and by-products and safe chemistry • Undertaking various ‘green’ chemistry processes • By deploying electrolysis fo
Slide 26: Expansive international presence with Marquee clientele
Expansive international presence with Marquee clientele 25
Slide 27: Fostered long term relationship with marquee clientele
Fostered long term relationship with marquee clientele while continuously expanding presence in global market ESTEEMED CUSTOMERS EXPORTS • Tatva exports products to over 25 countries viz. USA, China, Germany, Japan, South Africa and UK. • Subsidiaries facilitates overseas operations:- • Tatva Chinta
Slide 28: Why TATVA CHINTAN
Ze Why TATVA . CHINTAN @
Slide 29: Investment Rationale
Investment Rationale Strong position in Successful track Wide basket of Continuous focus High industry Capex to boost the the niche specialty record on widening products are used in on R&D and in house barriers as new capacities and pave chemicals space with product basket, varied industries develop
Slide 30: Industry Outlook
Industry Outlook 29
Slide 31: India's rapidly expanding footprint in Global Chemical Market
India's rapidly expanding footprint in Global Chemical Market SHARE OF COUNTRIES IN GLOBAL TRENDS IN SPECIALTY CHEMICALS LANDSCAPE CHEMICAL INDUSTRY (IN %) Indian Chemical Move towards Opportunity Industry got sustainable product for Indian CHINA 41% Advantage vs development: Manufacturers: EU 15% C
Slide 32: Global Chemical Industry
Global Chemical Industry GLOBAL Commodity Chemicals PTC SDA CHEMICAL • Basic Chemicals INDUSTRY • Manufactured In large volumes 1,031 964 Mkt Size Mkt Size MARKET SIZE • Mkt Size USD 3,700bn 2019 (USD Mn) 2019 (USD Mn) • ~Expected 6% CAGR 1,328 5.1% 1.4 6.8% Speciality Chemicals 4,738 • Value Added
Slide 33: Our Business
Our Business 32
Slide 34: Major Events & Milestones
Major Events & Milestones 1996 2007 2013 2017 2019 2021 Incorporation of our Expansion of Achieved turnover Set up our Dahej SEZ Incorporation of • Listed on Company manufacturing capacity at of ₹ 500.00 million Manufacturing Facility Tatva Chintan Europe BSE and NSE our Ankleshwar BV, a wholly owne
Slide 35: Leadership and Management
Leadership and Management Chintan Nitinkumar Shah Ajaykumar Mansukhlal Shekhar Rasiklal Somani Dr. Manher Chimanlal CA Subhash Ambubhai Dr. Avani Rajesh Umatt Patel Desai Patel M ANAG I N G D I R E C T O R WHOLE TIME DIRECTOR WHOLE TIME DIRECTOR I ND E P E ND E NT D I R E C T O R I ND E P E ND E NT
Slide 36: Shareholder Information
Shareholder Information SHAREHOLDING PATTERN- MARCH 2023 (IN %) NSE Ticker TATVA BSE Ticker 543321 IPO Listing Date 29 July 2021 Share Price (₹)^ 1,669 PROMOTER 79.17% Market Cap (₹ Mn)^ 36,995 MF 10.98% % Free Float^ 20.8% MARCH PUBLIC 5.35% Free float market cap (₹ Mn)^ 7,706 2023 Shares outstandi
Slide 37: Net IPO Proceeds
Net IPO Proceeds USE OF NET IPO PROCEEDS1 (IN ₹ MN) The Net Proceeds are utilized in accordance with the details provided in the following chart: Offer for Sale: Raised ₹2750 mn Fresh Issue: Raised ₹2250 mn 2,073 ISSUE SIZE ₹5,000 MILLION Capex at Dahej Plant Of: ₹1471 mn AT ₹1,083/SHARE 1,471 Capex
Slide 38: Safe Harbor
Safe Harbor Certain statements in this presentation concerning our future growth prospects are forward looking statements, which involve a number of risks, and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. The company's results may
Slide 39: Thank You
MAY 2023 Thank You TATVA CHINTAN PHARMA CHEM LIMITED INVESTOR RELATIONS AT CORPORATE OFFICE TATVA CHINTAN Plot No. 353, G.I.D.C, Mr. Ashok Bothra Makarpura, Vadodara – 390 010, Gujarat, India finance@tatvachintan.com BSE: 543321 EY NSE: TATVA Ms. Krishna Patel, Mr. Rahul Thakur CIN: L24232GJ1996PLC0
Tatva Chintan Pharma Chem — Q4 FY23 Earnings Presentation on 6ix